KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Long-Term Investments (2016 - 2026)

Eli Lilly filings provide 18 years of Long-Term Investments readings, the most recent being $3.1 billion for Q1 2026.

  • On a quarterly basis, Long-Term Investments fell 3.31% to $3.1 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $3.1 billion, a 3.31% decrease, with the full-year FY2025 number at $2.8 billion, down 12.87% from a year prior.
  • Long-Term Investments hit $3.1 billion in Q1 2026 for Eli Lilly, up from $2.8 billion in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $3.2 billion in Q1 2025 to a low of $2.6 billion in Q3 2022.
  • Median Long-Term Investments over the past 5 years was $2.9 billion (2024), compared with a mean of $2.9 billion.
  • Biggest five-year swings in Long-Term Investments: fell 25.55% in 2022 and later grew 18.89% in 2024.
  • Eli Lilly's Long-Term Investments stood at $2.9 billion in 2022, then grew by 5.18% to $3.1 billion in 2023, then grew by 5.37% to $3.2 billion in 2024, then dropped by 12.87% to $2.8 billion in 2025, then grew by 11.21% to $3.1 billion in 2026.
  • The last three reported values for Long-Term Investments were $3.1 billion (Q1 2026), $2.8 billion (Q4 2025), and $2.8 billion (Q3 2025) per Business Quant data.